Chronic obstructive pulmonary disease prevalence and severity in type 2 diabetic patients correlate to glycometabolic control and the presence of complications and co-morbidities

被引:0
|
作者
Lunati, M. E. [1 ]
Cappelletti, T. [2 ]
Masserini, B. [1 ]
Sburlati, L. F. [1 ]
Valenti, V. [3 ]
Blasi, F. B. [2 ]
Allegra, L. [2 ]
Beck-Peccoz, P. [1 ]
Orsi, E. [1 ]
机构
[1] Fdn Policlin, IRCCS, Dept Med Sci, Endocrinol & Diabet Unit, Milan, Italy
[2] Fdn Policlin, IRCCS, Inst Resp Dis, Milan, Italy
[3] Policlin San Donato Milanese, IRCCS, Inst Resp Dis, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1397
引用
收藏
页码:S562 / S562
页数:1
相关论文
共 50 条
  • [1] Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease
    Spicuzza, Lucia
    Campisi, Raffaele
    Crimi, Claudia
    Frasca, Emilio
    Crimi, Nunzio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 69 : E15 - E16
  • [2] Chronic obstructive pulmonary disease and cardiovascular co-morbidities
    Panuccio, Domenico
    Giusti, Massimo
    ITALIAN JOURNAL OF MEDICINE, 2008, 2 (03) : 42 - 46
  • [3] Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
    Spicuzza, Lucia
    Frasca, Emilio
    Doria, Giacomo
    Cacopardo, Giulia
    Crimi, Claudia
    Campisi, Raffaele
    Crimi, Nunzio
    Di Maria, Giuseppe
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Microalbuminuria in Chronic Obstructive Pulmonary Disease with and Without Co-morbidities
    Vyas, Hridyanshu
    Purohit, Purvi
    Dutt, Naveen
    Sharma, Praveen
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2019, 34 (03) : 367 - 368
  • [5] Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
    Ahmed, Maryam
    Leech, Karen
    Rickard, Barbara
    Lynch, Carol
    Owen, Gill
    Kempson, Wayne
    Allen, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [6] Microalbuminuria in Chronic Obstructive Pulmonary Disease with and Without Co-morbidities
    Hridyanshu Vyas
    Purvi Purohit
    Naveen Dutt
    Praveen Sharma
    Indian Journal of Clinical Biochemistry, 2019, 34 : 367 - 368
  • [7] Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease
    Areias, V.
    Carreira, S.
    Anciaes, M.
    Pinto, P.
    Barbara, C.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2014, 20 (01) : 5 - 11
  • [8] Severity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospital
    Au, L. H.
    Chan, H. S.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (06) : 498 - 503
  • [9] Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease
    MacNee, William
    ANNALS OF MEDICINE, 2013, 45 (03) : 291 - 300
  • [10] Influence of co-morbidities on the progression and prognosis of patients with chronic obstructive pulmonary disease in a Tunisian Hospital
    Ben Saad, Ahmed
    Loued, Lobna
    Joobeur, Samah
    Migaou, Asma
    Mhamed, Saousen Cheikh
    Rouatbi, Naceur
    Fahem, Nesrine
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 12